Slides

Glioma

Gliomas

Gliomas are the most common form of brain tumors, which begin in the glial (supportive) tissue. Different types of gliomas include astrocytomas, brain stem gliomas, ependymomas, and oligodendrogliomas.1 Based on the World Health Organization Grading System, grade I lesions generally have low proliferative potential with the possibility of a cure after surgical resection. Grade II…

POMALYST® (pomalidomide)

This slideshow reviews drug information for POMALYST® (pomalidomide). Table of Contents Slide 3: Indication, Dosage, and AdministrationSlide 6: Use in Specific PopulationsSlide 9: Clinical PharmacologySlide 13: Warnings and PrecautionsSlide 17: Clinical Safety and EfficacySlide 21: Drug Storage and Supply

Slide 1: Fatigue

14 Chemotherapy-Related Adverse Effects

Patients receiving treatment for cancer can experience a number of potential side effects and reactions. Clinicians should be aware of the adverse events that can result from administration of certain agents. Fatigue can result from a number of factors, including anemia, depression, and radiation therapy.1 Similarly, alopecia affects many patients and can be one of…

ZYTIGA® (abiraterone acetate)

This slideshow reviews drug information for ZYTIGA® (abiraterone acetate). Table of Contents Slide 3: Indication, Dosage, and AdministrationSlide 6: Use in Specific PopulationsSlide 9: Clinical PharmacologySlide 13: Warnings and PrecautionsSlide 16: Clinical Safety and EfficacySlide 22: Drug Storage and Supply

BOSULIF® (bosutinib)

This slideshow reviews drug information for BOSULIF® (bosutinib). Table of Contents Slide 3: Indication, Dosage, and AdministrationSlide 6: Use in Specific PopulationsSlide 9: Clinical PharmacologySlide 13: Warnings and PrecautionsSlide 16: Clinical Safety and EfficacySlide 22: Drug Storage and Supply

Iclusig™ (ponatinib)

This slideshow reviews drug information for Iclusig™ (ponatinib). Table of Contents Slide 3: Indication, Dosage, and AdministrationSlide 6: Use in Specific PopulationsSlide 9: Clinical PharmacologySlide 13: Warnings and PrecautionsSlide 16: Clinical Safety and EfficacySlide 21: Drug Storage and Supply

STIVARGA® (regorafenib)

This slideshow reviews drug information for STIVARGA® (regorafenib). Table of Contents Slide 3: Indication, Dosage, & AdministrationSlide 6: Use in Specific PopulationsSlide 9: Clinical PharmacologySlide 12: Warnings & PrecautionsSlide 16: Clinical Safety & EfficacySlide 22: Drug Storage & Supply

Marqibo® (vinCRIStine sulfate LIPOSOME injection)

This slideshow reviews drug information for MARQIBO® (vinCRIStine sulfate LIPOSOME injection). Table of Contents Slide 3: Indication, Dosage, & AdministrationSlide 7: Use in Specific PopulationsSlide 6: Clinical PharmacologySlide 13: Warnings & PrecautionsSlide 17: Clinical Safety & EfficacySlide 23: Drug Storage & Supply

Synribo™ (omacetaxine mepesuccinate)

This slideshow reviews drug information for Synribo™ (omacetaxine mepesuccinate). Table of Contents Slide 3: Indication, Dosage, and AdministrationSlide 7: Use in Specific PopulationsSlide 10: Clinical PharmacologySlide 14: Warnings and PrecautionsSlide 17: Clinical Safety and EfficacySlide 23: Drug Storage and Supply

Xtandi® (enzalutamide)

This slideshow reviews drug information for Xtandi® (enzalutamide). Table of Contents Slide 3: Indication, Dosage & AdministrationSlide 6: Use in Specific PopulationsSlide 9: Clinical PharmacologySlide 13: Warnings and PrecautionsSlide 15: Clinical Safety & EfficacySlide 19: Drug Storage & Supply

Next hm-slideshow in Slides